Gem Aromatics IPO Details

https://tredingmarket.com/

📊 Gem Aromatics IPO 2025 – Complete Details & Analysis

✅ IPO Snapshot

• IPO Type: Book Built Issue
• Total Issue Size: ₹451.25 Cr (1,38,84,615 shares)
  • Fresh Issue: ₹175 Cr (53,84,615 shares)
  • OFS: ₹276.25 Cr (85,00,000 shares)
• Face Value: ₹2 per share
• Price Band: ₹309 – ₹325
• Lot Size: 46 shares
• Minimum Investment (Retail): ₹14,950 (1 lot)
• Listing At: BSE & NSE
• Market Cap at Upper Price: ₹1,697.71 Cr

---

📅 IPO Timeline (Tentative)

• Anchor Bidding Date: Aug 18, 2025 (₹135.37 Cr raised)
• IPO Opens: Aug 19, 2025
• IPO Closes: Aug 21, 2025
• Allotment Finalization: Aug 22, 2025
• Refunds Initiation: Aug 25, 2025
• Shares to Demat: Aug 25, 2025
• Listing Date: Aug 26, 2025
• UPI Mandate Deadline: Aug 21, 2025, 5 PM

---

📌 IPO Reservation

• QIB: 50% (69,42,308 shares)
• NII (HNI): 15% (20,82,692 shares)
• Retail Investors: 35% (48,59,615 shares; ~1,05,643 retail allottees)
• Anchor: 30% (41,65,383 shares; lock-in 30/90 days)

---

📦 Lot Size & Investment

Investor Type	Min (Lots)	Shares	Amount (₹)
Retail Min	1	46	14,950
Retail Max	13	598	1,94,350
S-HNI Min	14	644	2,09,300
S-HNI Max	66	3,036	9,86,700
B-HNI Min	67	3,082	10,01,650

---

🏭 Company Overview – Gem Aromatics Ltd.

• Founded: 1997
• Business: Manufacturer of specialty ingredients – essential oils, aroma chemicals & derivatives.
• Product Segments:
  • Mint & derivatives
  • Clove & derivatives
  • Phenol
  • Other synthetic & natural ingredients
• Customer Base: 225 domestic clients + 44 international customers (18 countries).
• Exports: Direct, via Gem Aromatics LLC (USA), and 3rd party agencies.
• R&D Strength: 13 in-house scientists with focus on value-added derivatives.

---

💪 Competitive Strengths

• Wide product portfolio (70+ products).
• Strong R&D and continuous innovation.
• Long-standing global customer relationships.
• Strategically located manufacturing facilities.
• Experienced promoter family (Parekh family).

---

💰 Financial Performance (₹ Cr)

Particulars	FY23	FY24	FY25
Revenue	425.09	454.23	505.64
EBITDA	66.19	78.35	88.45
PAT	44.67	50.10	53.38
Net Worth	179.53	230.55	283.98
Total Borrowings	89.36	111.13	222.37

📈 Revenue grew 11% YoY (FY25), PAT up 7% YoY. Borrowings have doubled, but EBITDA margins remain stable at ~17.5%.

---

📌 Key Ratios & KPIs

• ROE: 18.80%
• ROCE: 16.02%
• PAT Margin: 10.56%
• EBITDA Margin: 17.55%
• Debt/Equity: 0.78
• Price-to-Book: 5.36

---

🧑‍🤝‍🧑 Promoter Holding

• Promoters: Vipul Parekh, Kaksha Vipul Parekh, Yash Vipul Parekh & Parekh Family Trust.
• Pre-Issue Holding: 75%
• Post-Issue Holding: 55.06%

Peer Comparison Snapshot

Metric	Pre-IPO (Using ₹11.39 EPS)	Post-IPO (Using ₹10.22 EPS)
EPS (₹)	11.39	10.22
P/E (x)	28.52×	31.8×

Industry Benchmark Insights

• Choice Broking notes that Gem Aromatics commands a P/E of 31.8× (based on FY25 EPS of ₹10.2), higher than many mid-cap chemical peers ChittorgarhThe Economic Times.
• Analysts at Swastika Investmart and Canara Bank Securities similarly highlight the valuation: “Fairly priced at 29× PE and 5× PB compared to 99× PE and 5× PB average of listed peers.” mint This suggests Gem Aromatics is attractively priced relative to high-growth peers, albeit still at a premium.
• Motilal Oswal’s IPO advertisement provides peer-level context:
  • Gem Aromatics: EPS ₹11.39, NAV ₹60.61.
  • Peer – Clean Science & Technology Ltd.: EPS ₹24.88, NAV ₹133.29. Motilal Oswal Group
  These figures show that peers may have stronger absolute earnings and net worth, possibly driving higher P/E multiples in the sector.

---

What This Implies

• Gem Aromatics trades at a solid premium, reflecting expectations of growth, strong niche positioning, and consistent financials.
• However, compared with some high-growth peers commanding P/Es near 99×, its valuation appears moderate and justifiable, especially for long-term investors.
• The comparison with Clean Science & Technology shows Gem has lower EPS and NAV, suggesting more headroom for growth or better efficiency could support its valuation.

---

Final Take

• Pre-IPO P/E (28.5×) vs. Post-IPO P/E (31.8×) indicates modest dilution—but still aligns with sector norms.
• Relative to high-growth peers, Gem Aromatics is reasonably priced.
• Comparison with Clean Science & Technology highlights potential upside if Gem elevates earnings/NAV through expansion or operational gains.

📝 Gem Aromatics IPO – Objectives, Review & Subscription Status

🎯 Objects of the Issue

The net proceeds from the IPO will be used for:

S.No.	Objective	Amount (₹ Cr)
1	Prepayment/repayment (full/part) of certain borrowings of the company & subsidiary (Krystal Ingredients Pvt. Ltd.)	140.00
2	General Corporate Purposes	Balance

---

📋 Expert Review

Dilip Davda’s View:

• GAL (Gem Aromatics Ltd.) manufactures specialty ingredients, aroma chemicals, and value-added derivatives.
• The company has shown steady growth in revenues & profits.
• Strong customer relationships with repeat orders.
• However:
  • The IPO is fully priced based on recent financials.
  • Operates in a highly competitive & fragmented sector.
• Recommendation: Well-informed investors may park moderate funds for the long term.

---

📊 Subscription Status (Final – Aug 21, 2025, 5:04 PM)

• Overall Subscription: 30.45×
• Category-wise:
  • Retail (RII): 10.49×
  • Qualified Institutional Buyers (QIB): 53.76×
  • Non-Institutional Investors (NII): 45.96×

👉 Strong QIB & HNI demand signals institutional confidence. Retail subscription at 10.5× also indicates high interest.

📊 Gem Aromatics IPO Subscription (Final Day – Aug 21, 2025)

Category	Subscription (times)	Shares Offered	Shares Bid For
QIB (Ex-Anchor)	53.76×	27,76,925	14,92,90,470
NII (HNI)	45.96×	20,82,692	9,57,15,834
└ bNII (₹10L+)	48.48×	13,88,462	6,73,12,950
└ sNII (<₹10L)	40.91×	6,94,231	2,84,02,884
Retail (RII)	10.49×	48,59,615	5,09,90,448
Total	30.45×	97,19,232	29,59,96,752

📌 Applications received: 10,59,134

---

🔍 Key Takeaways

• Massive QIB demand (53.8×): Strong institutional confidence, usually a bullish signal for listing.
• HNI demand (46×): Both small & big HNIs showed heavy interest, especially bNII (48.5×).
• Retail demand (10.5×): Well above average, showing strong participation from small investors.
• Overall (30.45×): Highly oversubscribed issue – indicates potential for strong listing gains.